Insider Buy/Sell Details for the Healthcare Sector — June 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2296)
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
7,833
Price
$109.75
Total Value
$859.67K
Shares Held After
2,394,256
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
10,658
Price
$108.28
Total Value
$1.15M
Shares Held After
2,402,089
% of Holdings
0.4%
Beta Bionics, Inc. (BBNX)
Feider Stephen — Chief Financial Officer
Shares
4,896
Price
$17.03
Total Value
$83.38K
Shares Held After
165,931
% of Holdings
2.9%
NEUROCRINE BIOSCIENCES INC (NBIX)
Lippoldt Darin — Chief Legal Officer
Shares
1,690
Price
$170.81
Total Value
$288.68K
Shares Held After
54,729
% of Holdings
3.0%
NEUROCRINE BIOSCIENCES INC (NBIX)
Lippoldt Darin — Chief Legal Officer
Shares
8,110
Price
$170.03
Total Value
$1.38M
Shares Held After
54,729
% of Holdings
12.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
430
Price
$548.96
Total Value
$236.05K
Shares Held After
40,513
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,702
Price
$548.29
Total Value
$933.19K
Shares Held After
40,943
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
759
Price
$547.12
Total Value
$415.26K
Shares Held After
42,645
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,705
Price
$546.28
Total Value
$931.40K
Shares Held After
43,404
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,165
Price
$545.30
Total Value
$1.18M
Shares Held After
45,109
% of Holdings
4.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,594
Price
$544.40
Total Value
$867.78K
Shares Held After
47,274
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
585
Price
$543.37
Total Value
$317.87K
Shares Held After
48,868
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$541.86
Total Value
$43.35K
Shares Held After
49,453
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$541.24
Total Value
$194.85K
Shares Held After
49,533
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$539.98
Total Value
$64.80K
Shares Held After
49,893
% of Holdings
0.2%
ANI PHARMACEUTICALS INC (ANIP)
CAREY STEPHEN P. — SVP & CFO
Shares
2,850
Price
$84.12
Total Value
$239.74K
Shares Held After
177,543
% of Holdings
1.6%
Monte Rosa Therapeutics, Inc. (GLUE)
Manning Anthony M. — Director
Shares
10,000
Price
$23.11
Total Value
$231.10K
Shares Held After
0
% of Holdings
100.0%
Privia Health Group, Inc. (PRVA)
Morris Matthew Shawn — Director
Shares
63,212
Price
$25.33
Total Value
$1.60M
Shares Held After
76,651
% of Holdings
45.2%
Monte Rosa Therapeutics, Inc. (GLUE)
Janku Filip — Chief Medical Officer
Shares
6,000
Price
$22.95
Total Value
$137.70K
Shares Held After
59,992
% of Holdings
9.1%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
55
Price
$84.59
Total Value
$4.65K
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
286
Price
$84.59
Total Value
$24.19K
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
9
Price
$84.59
Total Value
$761.31
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
349
Price
$84.59
Total Value
$29.52K
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
44,363
Price
$84.02
Total Value
$3.73M
Shares Held After
55
% of Holdings
99.9%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
229,334
Price
$84.02
Total Value
$19.27M
Shares Held After
286
% of Holdings
99.9%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
6,654
Price
$84.02
Total Value
$559.07K
Shares Held After
9
% of Holdings
99.9%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
279,671
Price
$84.02
Total Value
$23.50M
Shares Held After
349
% of Holdings
99.9%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
25,850
Price
$83.18
Total Value
$2.15M
Shares Held After
44,418
% of Holdings
36.8%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
133,633
Price
$83.18
Total Value
$11.12M
Shares Held After
229,620
% of Holdings
36.8%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
3,877
Price
$83.18
Total Value
$322.48K
Shares Held After
6,663
% of Holdings
36.8%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
162,965
Price
$83.18
Total Value
$13.55M
Shares Held After
280,020
% of Holdings
36.8%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
11,528
Price
$82.05
Total Value
$945.85K
Shares Held After
70,268
% of Holdings
14.1%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
59,592
Price
$82.05
Total Value
$4.89M
Shares Held After
363,253
% of Holdings
14.1%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
1,729
Price
$82.05
Total Value
$141.86K
Shares Held After
10,540
% of Holdings
14.1%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
72,672
Price
$82.05
Total Value
$5.96M
Shares Held After
442,985
% of Holdings
14.1%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
34,387
Price
$81.31
Total Value
$2.80M
Shares Held After
81,796
% of Holdings
29.6%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
177,768
Price
$81.31
Total Value
$14.45M
Shares Held After
422,845
% of Holdings
29.6%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
5,158
Price
$81.31
Total Value
$419.37K
Shares Held After
12,269
% of Holdings
29.6%
Hinge Health, Inc. (HNGE)
Insight Holdings Group, LLC — 10% Owner
Shares
216,787
Price
$81.31
Total Value
$17.63M
Shares Held After
515,657
% of Holdings
29.6%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
777
Price
$2.48
Total Value
$1.93K
Shares Held After
2,533,845
% of Holdings
0.0%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
63,985
Price
$2.47
Total Value
$158.04K
Shares Held After
2,533,068
% of Holdings
2.5%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
157,084
Price
$0.30
Total Value
$47.13K
Shares Held After
143,199
% of Holdings
52.3%
Pharvaris N.V. (PHVS)
Schikan Johannes Gerardus Christiaan Petrus — Director
Shares
2,400
Price
$35.10
Total Value
$84.25K
Shares Held After
352,767
% of Holdings
0.7%
Personalis, Inc. (PSNL)
Tachibana Aaron — CFO AND COO
Shares
4,982
Price
$14.00
Total Value
$69.75K
Shares Held After
198,833
% of Holdings
2.4%
CYTOKINETICS INC (CYTK)
Lee Sung — EVP, Chief Financial Officer
Shares
3,134
Price
$85.00
Total Value
$266.39K
Shares Held After
63,221
% of Holdings
4.7%
Imunon, Inc. (IMNN)
Eylward Susan — General Counsel and Corp Sec
Shares
11,800
Price
$1.75
Total Value
$20.67K
Shares Held After
2,896
% of Holdings
80.3%
Burning Rock Biotech Ltd (BNR)
Han Yusheng — Director
Shares
24,900
Price
$8.00
Total Value
$199.09K
Shares Held After
18,404,086
% of Holdings
0.1%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
325,000
Price
$34.07
Total Value
$11.07M
Shares Held After
14,501,546
% of Holdings
2.2%
Roivant Sciences Ltd. (ROIV)
MANCHESTER KEITH S — Director
Shares
300,783
Price
$33.92
Total Value
$10.20M
Shares Held After
14,826,546
% of Holdings
2.0%
Roivant Sciences Ltd. (ROIV)
Gold Daniel Allen — Director
Shares
325,000
Price
$34.07
Total Value
$11.07M
Shares Held After
14,501,546
% of Holdings
2.2%
Showing 151–200 of 2296 transactions (page 4 of 46)